23 November 2017
News and Views
Links and Services
Pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C, reports June's issue of the Alimentary Pharmacology & Therapeutics.
A previous meta-analysis established that pegylated interferon α-2a is more effective than p
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors